Abstract
Most forms of conventional cancer treatments are accompanied by undesirable side effects. Moreover, due to tumor heterogeneity, resistance to treatment and subsequent recurrence is often inevitable. Therefore, there is a need for development of progressive forms of adjuvant therapeutics. The tumor micro-environment is composed of tumor cells and multiple stromal cell types, including immune cells, many of which can produce pro-tumor chemokines and cytokines. The production of these molecules can result in a cascade effect, signaling other cells to promote an anti-cytotoxic, pro-tumor inflammatory response which hinders the necessary immune response needed to eliminate neoplastic cells. The pro-tumor inflammatory response is a key component during the progressive development of cancer. The “hijacking” of the immune system in the tumor environment provides a target which can be used to revert the immune system back to a type 1, pro-cytotoxic response. Natural compounds found in many traditional foods and medicines have a proven history of being anti-inflammatory, a key component which can be utilized during cancer treatment. Application of specific natural compounds in conjunction with conventional medicine can provide an additional level of support via modulation of the immune system. Phytochemicals found in turmeric, soy, and Scutellaria have shown profound effects on attenuating and modulating inflammation. This chapter looks into the mechanism of action and prospects for using these phytochemicals as an immune-modulatory adjuvant in the treatment of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abernathy LM et al (2015) Soy isoflavones promote radioprotection of normal lung tissue by inhibition of radiation-induced activation of macrophages and neutrophils. J Thorac Oncol 10(12):1703–1712
Abernathy LM et al (2017) Innate immune pathways associated with lung radioprotection by soy isoflavones. Front Oncol 7:7
Anthony RM et al (2007) Protective immune mechanisms in helminth infection. Nat Rev Immunol 7(12):975–987
Banerjee S et al (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269(2):226–242
Bharti AC et al (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101(3):1053
Bickel MM (1993) The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 64(5 suppl):456–460
Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214(2):149–160
Brouet I, Ohshima H (1995) Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206(2):533–540
Chang A (2011) Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71(1):3–10
Charles A, Janeway JARM (2002) Innate immune recognition. Annu Rev Immunol 20:197–216
Charlton B, Lafferty KJ (1995) The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 7(6):793–798
Choi J-S et al (2004) Flavones mitigate tumor necrosis factor-α-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-κB. J Nutr 134(5):1013–1019
Cortez-Retamozo V et al (2012) Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A 109(7):2491–2496
Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183:211–221
Dandawate S et al (2012) Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity. Cancer Immunol Immunother 61(5):701–711
Davis JN, Kucuk O, Sarkar FH (1999) Genistein inhibits NF-kB activation in prostate cancer cells. Nutr Cancer 35(2):167–174
Fan Y, Mao R, Yang J (2013) NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4(3):176–185
Fernandez de Simon B et al (1992) Importance of phenolic compounds for the characterization of fruit juices. J Agric Food Chem 40(9):1531–1535
Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33(5):949–955
Fridlender ZG et al (2009) Polarization of tumor-associated neutrophil (TAN) phenotype by TGF-β: “N1” versus “N2” TAN. Cancer Cell 16(3):183–194
Garg AD, Dudek AM, Agostinis P (2013) Cancer immunogenicity, danger signals, and DAMPs: what, when, and how? Biofactors 39(4):355–367
Gong L et al (2003) Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22(30):4702–4709
Gota VS et al (2010) Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58(4):2095–2099
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899
Hayden MSMSG (2004) Signaling to NF-κB. Genes Dev 18(18):2195–2224
Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115(1):1–20
Hoesel B, Schmid JA (2013) The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 12:86–86
Hussain F, Sandeep M, Joshee N, Parajuli P (2016) Application of bioactive compounds from Scutellaria in neurologic disorders. In: The benefits of natural products for neurodegenerative diseases. Springer, Basel, pp 79–93
Janeway CAC (1989) The priming of helper T cells. Semin Immunol 1(1):13–20
Janssen K et al (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 67(2):255–262
Kaiko GE et al (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 123(3):326–338
Kan X et al (2017) Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice. BMC Complement Altern Med 17:41
Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159–175
Kwon Y (2014) Effect of soy isoflavones on the growth of human breast tumors: findings from preclinical studies. Food Sci Nutr 2(6):613–622
Lacy P (2006) Mechanisms of degranulation in neutrophils. Allergy, Asthma Clin Immunol 2(3):98–108
Lafaille JJ (1998) The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 9(2):139–151
Lee ASJLYS (2013) Curcumin in various cancers. Biofactors 39(1):56–68
Lemberkovics E (1998) Phytochemical evaluation of essential oils, medicinal plants and their preparations. Acta Pharm Hung 68(3):141–149
Lesinski GB et al (2015) Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced pro-inflammatory cytokines and immune suppressive cells. Cancer Prevent Res 8(11):1036–1044
Li YY (2002) Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 186(2):157–164
Liang Y-C et al (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20(10):1945–1952
Lotze MT et al (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220(1):60–81
Lu Y-C, Yeh W-C, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine 42(2):145–151
MacEwan DJ (2002) TNF ligands and receptors – a matter of life and death. Br J Pharmacol 135(4):855–875
Mantovani A et al (2008) Cancer-related inflammation. Nature 454:436+
Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13
Mayadas TN, Cullere X, Lowell CA (2014) The multifaceted functions of neutrophils. Annu Rev Pathol 9:181–218
Messina M, Badger TM (2017) Health effects of isoflavones misrepresented. Food Chem 225:289–292
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969
Moudi M et al (2013) Vinca alkaloids. Int J Prev Med 4(11):1231–1235
Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4(3):a006049
Nielsen SE et al (2007) Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr 81(6):447–455
Norn SS (2009) From willow bark to acetylsalicylic acid. Dan Medicinhist Arbog 37:79–98
Oberley TD (2002) Oxidative damage and cancer. Am J Pathol 160(2):403–408
Parajuli P et al (2011) Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling. J Neuro-Oncol 101(1):15–24
Parameswaran N, Patial S (2010) Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 20(2):87–103
Patil RH et al (2016) Anti-inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells. Inflammation 39(1):138–147
Pavese JM, Farmer RL, Bergan RC (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29(3):465–482
Peng YY (2014) Immune and anti-oxidant functions of ethanol extracts of Scutellaria baicalensis Georgi in mice bearing U14 cervical cancers. Asian Pac J Cancer Prev 15(10):4129–4133
Pilaro AM et al (1994) TNF-alpha is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol 153(1):333
Prasad S, Aggarwal B (2011) Turmeric, the golden spice: from traditional medicine to modern medicine. In: Wachtel-Galor S, Benzie FF (eds) Herbal medicine: biomolecular and clinical aspects. CRC Press/Taylor & Francis, Boca Raton
Rath PCP (1999) TNF-induced signaling in apoptosis. J Clin Immunol 19(6):350–364
Reuter S et al (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49(11):1603–1616
Roach JC et al (2005) The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci U S A 102(27):9577–9582
Sabroe I et al (2008) The role of TLR activation in inflammation. J Pathol 214(2):126–135
Sandur SK et al (2007) Role of prooxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43(4):568–580
Singer AJ, Clark RAF (1999) Cutaneous wound healing. N Engl J Med 341(10):738–746
Singh S, Aggarwal BB (1995) Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270(42):24995–25000
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Bolger G, Helson L, Wolzt M (2015) Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther 53:54–65
Surh Y-J et al (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480–481:243–268
Takeuchi Y, Nishikawa H (2016) Roles of regulatory T cells in cancer immunity. Int Immunol 28(8):401–409
Tang D et al (2012) PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249(1):158–175
Testa JR, Tsichlis PN (2005) AKT signaling in normal and malignant cells. Oncogene 24(50):7391–7393
Thoppil RJ, Bishayee A (2011) Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J Hepatol 3(9):228–249
Tsan M-F (2006) Toll-like receptors, inflammation and cancer. Semin Cancer Biol 16(1):32–37
Vivier E et al (2008) Functions of natural killer cells. Nat Immunol 9(5):503–510
Wang J et al (2008) Genistein inhibits the development of atherosclerosis via inhibiting NF-κB and VCAM-1 expression in LDLR knockout mice. Can J Physiol Pharmacol 86(11):777–784
Wang N, Liang H, Zen K (2014a) Molecular mechanisms that influence the macrophage M1–M2 polarization balance. Front Immunol 5:614
Wang J et al (2014b) Anti-inflammatory effects of Apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway. Inflammation 37(6):2085–2090
Waugh DJJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735
Wong CK et al (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125(2):177–183
Wu JJ (2003) Natural killer cells and cancer. Adv Cancer Res 90:127–156
Xu B, Yu L, Zhao L-Z (2017) Curcumin up regulates T helper 1 cells in patients with colon cancer. Am J Transl Res 9(4):1866–1875
Yuan Zhang YZ, Gu W, Sun B (2014) Th1/Th2 cell differentiation and molecular signals. In: Sun B (ed) T helper cell differentiation and their function. Springer, Berlin, pp 15–34
Zhang J-M, An J (2007) Cytokines, inflammation and pain. Int Anesthesiol Clin 45(2):27–37
Zhang X et al (2014) Flavonoid Apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS One 9(9):e107072
Zhou XX (2014) Genistein antagonizes inflammatory damage induced by β-amyloid peptide in microglia through TLR4 and NF-κB. Nutrition 30(1):90–95
Zubair H et al (2017) Cancer chemoprevention by phytochemicals: Nature’s healing touch. Molecules 22(3):E395
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wright, R.E., Joshee, N., Parajuli, P. (2019). Modulation of Tumor Immunity by Medicinal Plant or Functional Food-Derived Compounds. In: Joshee, N., Dhekney, S., Parajuli, P. (eds) Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-31269-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-31269-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31268-8
Online ISBN: 978-3-030-31269-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)